James M. Hewitt

Array ( [id] => 9086391 [patent_doc_number] => 08557820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Crystal modifications of transmission dyes' [patent_app_type] => utility [patent_app_number] => 12/597930 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12347 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12597930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5417095 [patent_doc_number] => 20090042982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'METHOD FOR TREATING NEUROLOGICAL DISORDERS USING ACETONE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/101575 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10592 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042982.pdf [firstpage_image] =>[orig_patent_app_number] => 12101575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4507874 [patent_doc_number] => 07915254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Biologically active methylene blue derivatives' [patent_app_type] => utility [patent_app_number] => 12/078805 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16285 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915254.pdf [firstpage_image] =>[orig_patent_app_number] => 12078805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493680 [patent_doc_number] => 20100093700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Methods of Treating Mood Disorders' [patent_app_type] => utility [patent_app_number] => 12/531717 [patent_app_country] => US [patent_app_date] => 2008-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7266 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093700.pdf [firstpage_image] =>[orig_patent_app_number] => 12531717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201261 [patent_doc_number] => 08188146 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Highly purified ethyl EPA and other EPA derivatives' [patent_app_type] => utility [patent_app_number] => 12/052598 [patent_app_country] => US [patent_app_date] => 2008-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10229 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188146.pdf [firstpage_image] =>[orig_patent_app_number] => 12052598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4677039 [patent_doc_number] => 20080214670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Therapeutic Malonic Acid/Acetic Acid C60 Tri-Adducts of Buckminsterfullerene and Methods Related Thereto' [patent_app_type] => utility [patent_app_number] => 12/044634 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14103 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214670.pdf [firstpage_image] =>[orig_patent_app_number] => 12044634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4866390 [patent_doc_number] => 20080145449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Thiol reactive agents as a therapeutic modality' [patent_app_type] => utility [patent_app_number] => 12/070977 [patent_app_country] => US [patent_app_date] => 2008-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8790 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145449.pdf [firstpage_image] =>[orig_patent_app_number] => 12070977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6186669 [patent_doc_number] => 20110124690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CANCER OR A NEUROTROPHIC DISORDER' [patent_app_type] => utility [patent_app_number] => 12/528415 [patent_app_country] => US [patent_app_date] => 2008-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16137 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124690.pdf [firstpage_image] =>[orig_patent_app_number] => 12528415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4507802 [patent_doc_number] => 07915246 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain' [patent_app_type] => utility [patent_app_number] => 12/035820 [patent_app_country] => US [patent_app_date] => 2008-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7405 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915246.pdf [firstpage_image] =>[orig_patent_app_number] => 12035820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968866 [patent_doc_number] => 08507677 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Fluorescent probe' [patent_app_type] => utility [patent_app_number] => 12/526677 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6835 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12526677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4827037 [patent_doc_number] => 20080125453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'PHENYLEPHRINE TANNATE, PYRILAMINE TANNATE AND DEXTROMETHORPHAN TANNATE SALTS IN PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/028312 [patent_app_country] => US [patent_app_date] => 2008-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5131 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125453.pdf [firstpage_image] =>[orig_patent_app_number] => 12028312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6617259 [patent_doc_number] => 20100324017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'ACYLGUANIDINE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/526250 [patent_app_country] => US [patent_app_date] => 2008-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27282 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20100324017.pdf [firstpage_image] =>[orig_patent_app_number] => 12526250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307172 [patent_doc_number] => 20100069401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'USE OF CATECHOLAMINES AND RELATED COMPOUNDS AS ANTI-ANGIOGENIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/448981 [patent_app_country] => US [patent_app_date] => 2008-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13707 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069401.pdf [firstpage_image] =>[orig_patent_app_number] => 12448981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6128223 [patent_doc_number] => 20110086908 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2011-04-14 [patent_title] => 'USE OF PHOSPHATASE INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 12/524011 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8600 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0086/20110086908.pdf [firstpage_image] =>[orig_patent_app_number] => 12524011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955473 [patent_doc_number] => 20080188497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Dipyridamole, Acetylsalicylic Acid, and Angiotensin II Antagonist Pharmaceutical Compositions' [patent_app_type] => utility [patent_app_number] => 12/014181 [patent_app_country] => US [patent_app_date] => 2008-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1952 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188497.pdf [firstpage_image] =>[orig_patent_app_number] => 12014181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4764620 [patent_doc_number] => 20080175831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'NEUROPROTECTION BY BLOOD FLOW STABILIZATION' [patent_app_type] => utility [patent_app_number] => 11/961835 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8294 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175831.pdf [firstpage_image] =>[orig_patent_app_number] => 11961835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5297155 [patent_doc_number] => 20090012081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells' [patent_app_type] => utility [patent_app_number] => 12/002273 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 55013 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012081.pdf [firstpage_image] =>[orig_patent_app_number] => 12002273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6375619 [patent_doc_number] => 20100076037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'Methods of Treating Neuropathic Pain with Agonists of PPAR-gamma' [patent_app_type] => utility [patent_app_number] => 12/513234 [patent_app_country] => US [patent_app_date] => 2007-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20344 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20100076037.pdf [firstpage_image] =>[orig_patent_app_number] => 12513234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4966220 [patent_doc_number] => 20080109040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'METHOD OF TREATING ARRHYTHMIAS' [patent_app_type] => utility [patent_app_number] => 11/932291 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 63 [patent_no_of_words] => 24840 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20080109040.pdf [firstpage_image] =>[orig_patent_app_number] => 11932291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927916 [patent_doc_number] => 20080167279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'PREVENTION OF OVARIAN CANCER BY ADMINISTRATION OF PRODUCTS THAT INDUCE BIOLOGIC EFFECTS IN THE OVARIAN EPITHELIUM' [patent_app_type] => utility [patent_app_number] => 11/931425 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40590 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167279.pdf [firstpage_image] =>[orig_patent_app_number] => 11931425 [rel_patent_id] =>[rel_patent_doc_number] =>)